Drug-eluting stents : IImplications for modern coronary revascularization [Drug-eluting Stents : Implikationen für die moderne Koronarrevaskularisation]

被引:0
|
作者
Martens A. [1 ]
Haverich A. [1 ]
机构
[1] Klinik für Herz-, Thorax-, Transplantations- und Gefäß chirurgie, Medizinische Hochschule, 30625 Hannover
来源
Der Chirurg | 2009年 / 80卷 / 6期
关键词
Coronary intervention; Coronary revascularization; Coronary surgery; Drug-eluting stent; Reintervention;
D O I
10.1007/s00104-008-1657-9
中图分类号
学科分类号
摘要
Despite considerable data and years of experience in the field of coronary interventions and coronary surgery existing guidelines, which are still valid in the era of drug-eluting stents (DES), are often not followed. An increasing number of patients are treated with DES implantations against current recommendations. Due to antiplatelet therapy this impedes the planning and execution of additional invasive procedures that might be necessary after DES implantation and results in higher risks, if delaying treatment is not possible. As alternatives to stent implantation, coronary surgery nowadays offers a full range of individual treatment options which are highly effective and durable. They can be performed at low risk and do not interfere with subsequent invasive therapies. Patients suffering from relevant coronary artery disease and who are in need of additional invasive treatment should be considered for coronary surgery rather than stent implantation. If current guidelines are followed more closely, DES implantations and their accompanying drawbacks could be significantly reduced. © 2009 Springer Medizin Verlag.
引用
收藏
页码:508 / 514
页数:6
相关论文
共 50 条
  • [1] Drug-eluting stents : IImplications for surgery patients [Drug-eluting Stents : Auswirkungen für chirurgische Patienten]
    Bölükbas S.
    Jähne J.
    Schirren J.
    [J]. Der Chirurg, 2009, 80 (6): : 502 - 507
  • [2] Drug-eluting stents Implications for modern coronary revascularization
    Martens, A.
    Haverich, A.
    [J]. CHIRURG, 2009, 80 (06): : 508 - +
  • [3] Novel drug-eluting stents for coronary revascularization
    Gogas, Bill D.
    McDaniel, Michael
    Samady, Habib
    King, Spencer B., III
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2014, 24 (07) : 305 - 313
  • [4] Drug-eluting coronary stents
    Salam, AM
    Al Suwaidi, J
    Holmes, DR
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2006, 31 (01) : 8 - 119
  • [5] Drug-eluting Coronary Stents
    Zeus, T.
    Kelm, M.
    Nitschmann, S.
    [J]. INTERNIST, 2014, 55 (01): : 103 - 106
  • [6] Drug-eluting stents, restenosis and revascularization
    Ramcharitar, Steve
    Gaster, Anne Louise
    Daemen, Joost
    Serruys, Patrick
    [J]. HERZ, 2007, 32 (04) : 287 - 295
  • [7] Hybrid coronary revascularization in the era of drug-eluting stents
    Murphy, GJ
    Bryan, AJ
    Angelini, GD
    [J]. ANNALS OF THORACIC SURGERY, 2004, 78 (05): : 1861 - 1867
  • [8] What reimbursement for coronary revascularization with drug-eluting stents?
    Tarricone R.
    Marchetti M.
    Lamotte M.
    Annemans L.
    De Jong P.
    [J]. The European Journal of Health Economics, 2004, 5 (4) : 309 - 316
  • [9] Diabetes and Percutaneous Coronary Revascularization in the Drug-Eluting Stent EraDiabetes mellitus und perkutane Koronarrevaskularisation im Zeitalter der Drug-eluting Stents
    David M. Safley
    Steven P. Marso
    [J]. Herz, 2004, 29 (5) : 542 - 550
  • [10] Drug-eluting stents
    Scheller, B
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 2004, 93 (09): : 646 - 648